logo
更新:2024-03-22
PV Specialist (MJ000932)全国
7千-1.2万
南京江宁区  | 1-3年  | 本科  | 社招
已结束
职位详情
五险一金
年终奖金
带薪年假
团队聚餐
子女福利
节日礼物
定期体检
领导好
岗位晋升
发展空间大
Primary

Responsibilities:

1.    Is responsible for ensuring global regulatory reporting compliance by execution of processes and compliance with procedures for processing adverse experience reports originating from

clinical studies, literature, and the marketplace for client specific products.

2.    Identifying and capturing accurately the relevant information of ICSRs (Including serious and non-serious cases from unsolicited and solicited origin; and literature cases, as required) in the client’s database in accordance with client conventions/guidelines and SOPs, and liaising with the client if applicable.

3.    Is responsible for narrative writing.

4.    Ensures the timely completion and distribution of AE/SAE reports to Health Authorities, client partners, and clients.

5.    Ensures timely identification of Individual Case Safety Reports and/or relevant safety information during the monitoring of the literature.

6.    Maintaining a basic working knowledge of the adverse event safety profile of assigned drugs and labeling documents or IB.

7.    Requesting additional information from the appropriate sender (investigators, medical representatives etc.), as required.

Qualifications

1.    Degree in life sciences’ or a prior experience in PV would be desirable.

2.    The minimum qualification required would be a college/bachelor degree.

3.    Basic conversational skills in English required.

4.    Computer proficiency, an ability to work with web-based applications, and familiarity with the Windows Professional Operating System and the MS office suite (MS Word/Excel/PowerPoint).

5. Demonstrate understanding or ability to learn and demonstrate understanding of SOPs, WPDs, and relevant regulations e.g. ICH/GCP, Clinical trial guidelines).

其他信息
语言要求:英语、普通话
工作地址
南京-江宁区南岸瑞智文创园
公司介绍
昆翎(ClinChoice)是一家致力于为生物医药和医疗器械客户提供高品质一站式服务的临床阶段CRO,服务包括临床运营、项目管理、生物统计、数据管理、注册事务、医学事务和药物警戒。昆翎已经在中国、美国、欧洲、印度、日本和菲律宾建立了主要的临床交付中心,目前在全球拥有1800多名员工,其临床运营团队覆盖了亚、欧、北美等七个国家和地区。
高盛直投部董事总经理、昆翎董事会成员许小鸥先生认为,“随着创新疗法在全球的增长,CRO公司提供高效、可靠的研发服务能力变得尤其重要。昆翎独特的价值主张结合了其对于本地市场的了解、国际药物研发的经验以及高效的团队执行能力。我们坚信公司强劲的管理层团队以及其高效的执行能力,将为昆翎的发展开启新的篇章。
若用人单位提供虚假招聘信息,以担保或其他任何名义收取财物,扣押或以保管为名索要证件,都属于违法行为,应当提高警惕。
发布于